BioVie Inc.BIVINASDAQ
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | -82.58% | -58.82% | +313.10% | +2383.40% | +714.95% |
| Weighted Average Shares Diluted Growth | -82.58% | -58.82% | +313.10% | +2316.71% | +714.95% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -10.62% | +19.56% | -22.39% | -14.46% | +26.28% |
| Book Value per Share Growth | +969.72% | +675.55% | -72.09% | -95.06% | -78.26% |
| Debt Growth | -69.99% | -96.28% | -95.65% | -94.27% | -91.05% |
| R&D Expense Growth | -77.58% | -27.29% | -76.41% | -40.39% | +47.54% |
| SG&A Expenses Growth | -100.00% | +0.00% | +0.00% | -11.11% | +0.00% |